Ionis Pharmaceuticals Inc (NAS:IONS) Stock News, Headlines & Updates
Ionis Pharmaceuticals Inc Stock News from GuruFocus
- 1
Jul 01, 2025
Ionis Pharmaceuticals (IONS): Barclays Upgrades and Raises Price Target | IONS Stock News
GuruFocus News • 7:31am
Jun 26, 2025
Ionis Pharmaceuticals (IONS) Receives Reiterated 'Buy' Rating with Stable Price Target | IONS Stock News
GuruFocus News • 7:00am
Jun 25, 2025
Ionis Pharmaceuticals Announces Promising Phase 1 Results for Salanersen in SMA Treatment | IONS stock news
GuruFocus News • 7:01am
Ionis announces Biogen to advance salanersen into SMA registrational studies based on positive interim Phase 1 results
Business Wire • 7:00am
Ionis announces Biogen to advance salanersen into SMA registrational studies based on positive interim Phase 1 results | IONS Stock News
GuruFocus News • 6:45am
Jun 12, 2025
JP Morgan Maintains Neutral Rating, Raises Price Target for Ionis Pharmaceuticals (IONS) | IONS Stock News
GuruFocus News • 9:01am
Ionis announces Dr. Richard Geary, chief development officer, to retire; Dr. Holly Kordasiewicz to assume role in January 2026
Business Wire • 9:00am
Ionis Pharmaceuticals (IONS) Announces Leadership Change in Development | IONS Stock News
GuruFocus News • 8:46am
Ionis announces Dr. Richard Geary, chief development officer, to retire; Dr. Holly Kordasiewicz to assume role in January 2026 | IONS Stock News
GuruFocus News • 8:23am
JPMorgan Adjusts Ionis Pharmaceuticals (IONS) Price Target to $48 | IONS Stock News
GuruFocus News • 6:45am
Jun 11, 2025
Ionis Pharmaceuticals Inc (IONS) Initiates Phase 3 REVEAL Study for Angelman Syndrome Treatment | IONS stock news
GuruFocus News • 7:06am
First patient dosed in pivotal Phase 3 REVEAL clinical study of ION582 in Angelman syndrome
Business Wire • 7:00am
Ionis Pharmaceuticals (IONS) Advances with Phase 3 REVEAL Study for Angelman Syndrome | IONS Stock News
GuruFocus News • 6:31am
First patient dosed in pivotal Phase 3 REVEAL clinical study of ION582 in Angelman syndrome | IONS Stock News
GuruFocus News • 6:21am
May 20, 2025
Ionis Pharmaceuticals (IONS) Receives Buy Rating from HC Wainwright & Co. | IONS Stock News
GuruFocus News • 6:31am
May 19, 2025
Ionis Pharmaceuticals Announces Positive Results from Olezarsen Study | IONS stock news
GuruFocus News • 7:04am
Ionis announces positive topline results from Essence study of olezarsen in people with moderately elevated triglycerides
Business Wire • 7:00am
Ionis Pharmaceuticals (IONS) Reports Positive Results from Olezarsen Study | IONS Stock News
GuruFocus News • 6:32am
Ionis announces positive topline results from Essence study of olezarsen in people with moderately elevated triglycerides | IONS Stock News
GuruFocus News • 6:19am
May 06, 2025
Ionis to host 2025 virtual Annual Meeting of Stockholders
Business Wire • 7:00am
Ionis to host 2025 virtual Annual Meeting of Stockholders | IONS Stock News
GuruFocus News • 6:18am
May 01, 2025
IONIS: Guggenheim Maintains Buy Rating but Lowers Price Target | IONS Stock News
GuruFocus News • 11:25am
Ionis Pharmaceuticals (IONS) Receives Price Target Boost from HC Wainwright | IONS Stock News
GuruFocus News • 11:10am
Ionis Pharmaceuticals (IONS) Target Price Increased to $50 After Strong Q1 | IONS Stock News
GuruFocus News • 7:30am
Ionis Pharmaceuticals (IONS) Target Price Adjusted by Guggenheim | IONS Stock News
GuruFocus News • 6:22am
Ionis Pharmaceuticals Inc (IONS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements
GuruFocus News • 1:16am
Q1 2025 Ionis Pharmaceuticals Inc Earnings Call Transcript
GuruFocus News • 11:15pm
Apr 30, 2025
Ionis Pharmaceuticals (IONS) Projects Revenue Growth with TRYNGOLZA Success
GuruFocus News • 1:58pm
Ionis Pharmaceuticals (IONS) Q1 2025 Earnings: Revenue Surpasses Estimates at $132M, EPS Loss Matches Expectations
GuruFocus News • 10:32am
Ionis Pharmaceuticals (IONS) Boosts 2025 Revenue Guidance and Strengthens Financial Position | IONS Stock News
GuruFocus News • 7:18am
Ionis reports first quarter 2025 financial results
Business Wire • 7:00am
Ionis (IONS) Sees Strong Q1 Revenue with New Launches Fueling Growth | IONS Stock News
GuruFocus News • 6:31am
Ionis reports first quarter 2025 financial results | IONS Stock News
GuruFocus News • 6:23am
Apr 29, 2025
New Harris Poll findings reveal HAE patients are unsatisfied with current prophylactic treatment options, with over 90% interested in trying new therapies
Business Wire • 7:00am
New Harris Poll findings reveal HAE patients are unsatisfied with current prophylactic treatment options, with over 90% interested in trying new therapies | IONS Stock News
GuruFocus News • 6:21am
Apr 16, 2025
Ionis to hold first quarter 2025 financial results webcast
Business Wire • 7:00am
Ionis to hold first quarter 2025 financial results webcast | IONS Stock News
GuruFocus News • 6:17am
Apr 11, 2025
Ionis Pharmaceuticals (IONS) Sees Price Target Cut by Morgan Stanley | IONS Stock News
GuruFocus News • 8:31am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news